Cullinan Oncology, Inc. (CGEM) Tops Q3 EPS by 18c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q3 EPS of ($0.77), $0.18 better than the analyst estimate of ($0.95).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Lyft to acquire Serveo's bikeshare business in Spain
• QXO, Inc. (QXO) call put ratio 1.2 calls to 1 put as share price down 8.3%
• Trump: I think Israel will withdraw troops from Lebanon